Evidence map›Paper›PMID 27893795›Full record

ArticlePloS one2016

Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC.

Luisa Maria Nieto R, Carolina Mehaffy, Elizabeth Creissen, JoLynn Troudt, Amber Troy, Helle Bielefeldt-Ohmann, Marcos Burgos, Angelo Izzo, Karen M Dobos

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Mutations inInfection and drug resistance · 2026
    Article
  2. Article
  3. Review
  4. TowardMicroorganisms · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Coevolution ofMicrobiology spectrum · 2023
    Article
  9. Drug-resistant strains ofFrontiers in cellular and infection microbiology · 2023
    Review
  10. Article
  11. Article
  12. Evolution of Drug-ResistantFrontiers in microbiology · 2021
    Review
  13. Review
  14. Bayesian reconstruction ofMicrobial genomics · 2020
    Article
  15. Article
  16. Two NovelFrontiers in microbiology · 2020
    Article
  17. Whole Genome and Transcriptome Sequencing of Two Multi-Drug ResistantFrontiers in cellular and infection microbiology · 2020
    Article
  18. Article
  19. Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2019
    Article
  20. Biochemical Characterization of Isoniazid-resistantMolecular & cellular proteomics : MCP · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Luisa Maria Nieto RDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.
Carolina MehaffyDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.ORCID http://orcid.org/0000-0002-7634-5131
Elizabeth CreissenDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.
JoLynn TroudtDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.
Amber TroyDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.
Helle Bielefeldt-OhmannSchool of Veterinary Science, University of Queensland, Gatton, Queensland, Australia; Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia.
Marcos BurgosDivision of Infectious Diseases, Department of Medicine, University of New Mexico, Albuquerque, New Mexico, United States of America.
Angelo IzzoDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.
Karen M DobosDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.ORCID http://orcid.org/0000-0001-7115-8524
Colorado State University · USThe University of Queensland · AUUniversity of New Mexico · US

Funding

NIAID NIH HHS HHSN272201000009I
6 · The paper itself

Abstract

In the last decade, there were 10 million new tuberculosis cases per year globally. Around 9.5% of these cases were caused by isoniazid resistant (INHr) Mycobacterium tuberculosis (Mtb) strains. Although isoniazid resistance in Mtb is multigenic, mutations in the catalase-peroxidase (katG) gene predominate among the INHr strains. The effect of these drug-resistance-conferring mutations on Mtb fitness and virulence is variable. Here, we assessed differences in bacterial growth, immune response and pathology induced by Mtb strains harboring mutations at the N-terminus of the katG gene. We studied one laboratory and one clinically isolated Mtb clonal pair from different genetic lineages. The INHr strain in each pair had one and two katG mutations with significantly reduced levels of the enzyme and peroxidase activity. Both strains share the V1A mutation, while the double mutant clinical INHr had also the novel E3V katG mutation. Four groups of C57BL/6 mice were infected with one of the Mtb strains previously described. We observed a strong reduction in virulence (reduced bacterial growth), lower induction of proinflammatory cytokines and significantly reduced pathology scores in mice infected with the clinical INHr strain compared to the infection caused by its INHs progenitor strain. On the other hand, there was a subtle reduction of bacteria growth without differences in the pathology scores in mice infected with the laboratory INHr strain. Our results also showed distinct alkyl-hydroperoxidase C (AhpC) levels in the katG mutant strains, which could explain the difference in the virulence profile observed. The difference in the AhpC levels between clonal strains was not related to a genetic defect in the gene or its promoter. Cumulatively, our results indicate that the virulence, pathology and fitness of INHr strains could be negatively affected by multiple mutations in katG, lack of the peroxidase activity and reduced AhpC levels.

Indexed as

AnimalsAntitubercular AgentsBacterial ProteinsCatalaseCytokinesDrug Resistance, BacterialFemaleIsoniazidLungMice, Inbred C57BLMutationMycobacterium tuberculosisPeroxidasesTuberculosisAntitubercular AgentsBacterial ProteinsCatalaseCytokinesIsoniazidkatG protein, Mycobacterium tuberculosisPeroxidases

Identifiers

PMID27893795
PMCPMC5125630
OpenAlexW2558789624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.